Makaleler

Tümü (13)

SCI-E, SSCI, AHCI (10)

SCI-E, SSCI, AHCI, ESCI (11)

Scopus (12)

TRDizin (1)

Diğer Yayınlar (1)

2010

2010

1. Electron microscopic findings in non-alcoholic fatty liver disease: Is there a difference between hepatosteatosis and steatohepatitis?

Ahishali E., Demir K., Ahishali B., Akyuz F., Pinarbasi B., Poturoglu S., et al.

Journal of Gastroenterology and Hepatology (Australia) , cilt.25, sa.3, ss.619-626, 2010 (SCI-Expanded)

2009

2009

2. The quality of life in hemodialysis patients with chronic hepatitis C virus infection

Akyuz F., Besisik F., Pinarbasi B., Demir K., Kaymakoglu S., Cakaloglu Y., et al.

Turkish Journal of Gastroenterology , cilt.20, sa.4, ss.243-246, 2009 (SCI-Expanded)

2009

2009

3. Are acquired hepatocerebral degeneration and hepatic myelopathy reversible?

Pinarbasi B., Kalymakoglu S., Matur Z., Akyuz F., Demir K., Besisik F., et al.

Journal of clinical gastroenterology , cilt.43, sa.2, ss.176-81, 2009 (SCI-Expanded)

2008

2008

4. Intestinal metaplasia in portal hypertensive gastropathy: A frequent pathology

Ibrisim D., Cevikbas U., Akyuz F., Poturoglu S., Ahishali E., Gulluoglu M., et al.

European Journal of Gastroenterology and Hepatology , cilt.20, sa.9, ss.874-880, 2008 (SCI-Expanded)

2007

2007

5. Pegylatedd interferon alfa-2b monotherapy and pegylated interferon alfa-2b plus lamivudine combination therapy for patients with hepatitis B virus E antigen-negative chronic hepatitis B

Kaymakoglu S., Oguz D., Gur G., Gurel S., Tankurt E., Ersoz G., et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY , cilt.51, sa.8, ss.3020-3022, 2007 (SCI-Expanded)

2007

2007

6. What is the reason of elevated alanine aminotransferase level in HBeAg negative patients with low viremia: NAFLD or chronic hepatitis?

Demir K., Akyuz F., Ozdil S., Aksoy N., Kaymakoglu S., Poturoglu S., et al.

Annals of Hepatology , cilt.6, sa.2, ss.92-96, 2007 (Scopus)

2007

2007

7. Long-term results of interferon alpha monotherapy in patients with HBeAg-negative chronic hepatitis B

Kaymakoglu S., Danalioglu A., Demir K., Karaca C., Akyuz F., Onel D., et al.

Digestive Diseases and Sciences , cilt.52, sa.3, ss.727-731, 2007 (SCI-Expanded)

2007

2007

8. Lamivudine monotherapy and lamivudine plus interferon alpha combination therapy in HBeAg negative chronic hepatitis B not responding to previous interferon alpha monotherapy

Akyuz F., Kaymakoglu S., Demir K., Aksoy N., Karaca C., Danalioglu A., et al.

Acta Gastro-Enterologica Belgica , cilt.70, sa.1, ss.20-24, 2007 (SCI-Expanded)

2006

2006

9. Treatment of hepatic hydrothorax with terlipressin in a cirrhotic patient

Ibrisim D., Cakaloglu Y., Akyuz F., Karadag A., Ozdil S., Besisik F., et al.

Scandinavian Journal of Gastroenterology , cilt.41, sa.7, ss.862-865, 2006 (SCI-Expanded)

2005

2005

10. Intrahepatic and peripheral T-cell responses in genotype 1b hepatitis C virus-infected patients with persistently normal and elevated aminotransferase levels

Akyuz F., Polat N., Kaymakoglu S., Aksoy N., Demir K., Besisik F., et al.

World Journal of Gastroenterology , cilt.11, sa.45, ss.7188-7191, 2005 (SCI-Expanded)

2005

2005

11. Sexual transmission of HCV between spouses

Tahan V., Karaca C., Yildirim B., Bozbaş A., Ozaras R., Demir K., et al.

American Journal of Gastroenterology , cilt.100, sa.4, ss.821-824, 2005 (SCI-Expanded)

2005

2005

12. Is there any medical therapeutic option in hepatopulmonary syndrome? A case report

AKYÜZ F., KAYMAKOĞLU S., DEMİR K., Aksoy N., Adalet I., Ökten A.

European Journal of Internal Medicine , cilt.16, sa.2, ss.126-128, 2005 (Scopus)

1992

1992

13. Sağlık personeli olmak HCV infeksiyonu açısından risk faktörü mü ? Asemptomatik sağlık personelinde HCV seroprevalansı.

Beşışık F., Ökten A., Kaymakoğlu S., BADUR O. S., Yalçın S., AĞAÇFİDAN A.

Gastroenterohepatoloji , cilt.3, sa.3, ss.169-171, 1992 (Hakemli Dergi)